Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (the OPTIMAAL trial)

This publication has 9 references indexed in Scilit:

• Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
  The Lancet, 2000
• Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure
  The American Journal of Cardiology, 2000
• Angiotensin II Type 1A Receptor Knockout Mice Display Less Left Ventricular Remodeling and Improved Survival After Myocardial Infarction
  Circulation, 1999
• Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design
  The American Journal of Cardiology, 1999
• Angiotensin Production by the Heart
  Circulation, 1998
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
  Published by Elsevier ,1997
• Inhibition of the renin-angiotensin system after acute myocardial infarction treat first, select later?
  Heart, 1996
• ACE Inhibitor Use in Patients With Myocardial Infarction
  Circulation, 1995
• Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
  JAMA, 1995